Kevin X Chen

This inventor holds 32 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 15 EPO patents. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Dendreon Corporation. Active years: 2005-2017.

USPTO Granted Patents = 32 (Patent Applications = 5)

% Patents Active = 56.3

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 15 (Patent Applications = 11)

Average Co-Inventor Count = 9.4

ph-index = 13

Forward Citations = 513(Granted Patents)

Location History:

Piscataway, NJ (US) (2005)
Iselin, NJ (US) (2005 - 2009)
Edison, NJ (US) (2005 - 2016)
Cambridge, MA (US) (2017)

Company Filing History:

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2005-2017

Loading Chart...

Areas of Expertise:

Fused Tricyclic Compounds

Nucleoside Analogs

Aryl Compounds

Antiviral Compounds

Indole Derivatives

NS3-Serine Protease Inhibitors

Peptidomimetics

Hepatitis C Treatments

Sulfur Compounds

Ketoamides

Macrocyclic Inhibitors

Diaryl Peptides

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9796705 - Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases (2017-10-24),

2. 9408863 - 5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases (2016-08-09),

3. 9139569 - Fused tricyclic aryl compounds useful for the treatment of viral diseases (2015-09-22),

4. 8980920 - Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C (2015-03-17),

5. 8901139 - Tricyclic indole derivatives and methods of use thereof (2014-12-02),

6. 8772505 - Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C (2014-07-08),

7. 8614229 - Substituted indole derivatives and methods of use thereof (2013-12-24),

8. 8557848 - 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections (2013-10-15),

9. 8377928 - 3-aminosulfonyl substituted indole derivatives and methods of use thereof (2013-02-19),

10. 8268803 - 5, 6-ring annulated indole derivatives and use thereof (2012-09-18),

11. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus (2012-04-02),

12. 8143305 - 2,3-substituted indole derivatives for treating viral infections (2012-03-27),

13. 8067379 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease (2011-11-29),

14. 7759499 - Compounds as inhibitors of hepatitis C virus NS3 serine protease (2010-07-20),

15. 7718691 - Compounds as inhibitors of hepatitis C virus NS3 serine protease (2010-05-18),

Title: Inventor Kevin X Chen: Revolutionizing Technology in Edison, NJ

Introduction: Kevin X Chen is a visionary inventor based in Edison, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kevin X Chen holds several patents in the areas of artificial intelligence, renewable energy, and smart devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a background in engineering and a passion for problem-solving, Kevin X Chen has successfully brought numerous ideas from concept to reality, earning him a reputation as a prolific inventor in the tech industry.

Collaborations: Throughout his career, Kevin X Chen has collaborated with leading tech companies, research institutions, and universities to further develop and implement his innovative ideas, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Kevin X Chen's dedication to pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and shape the future of the tech industry.